about
Drug delivery of lipophilic pyrenyl derivatives by encapsulation in a water soluble metalla-cage.Thiophenolato-bridged dinuclear arene ruthenium complexes: a new family of highly cytotoxic anticancer agents.Double targeting of tumours with pyrenyl-modified dendrimers encapsulated in an arene-ruthenium metallaprism.Encapsulation of pyrene-functionalized poly(benzyl ether) dendrons into a water-soluble organometallic cage.Delivery of floxuridine derivatives to cancer cells by water-soluble organometallic cages.Enhancement of cytotoxicity by combining pyrenyl-dendrimers and arene ruthenium metallacages.BODIPY-phosphane as a versatile tool for easy access to new metal-based theranostics.Protein ruthenation and DNA alkylation: chlorambucil-functionalized RAPTA complexes and their anticancer activity.Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters.Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties.Drug Repurposing Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma Treatment.Anthracene-tethered ruthenium(II) arene complexes as tools to visualize the cellular localization of putative organometallic anticancer compoundsHighly cytotoxic trithiophenolatodiruthenium complexes of the type [(η6-p-MeC6H4Pr i )2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential
P50
Q33651290-9375C718-D8DC-4488-A6BA-2A7C80EA3425Q33708966-F3342C73-6B4C-4951-84C5-D4150B457658Q33806089-042B40A4-EE95-42F9-96E1-4F32E51ADEC5Q33917124-F3C73B98-00D9-4C98-AF3A-77CD08F22F82Q34134298-A03C03A2-76E6-493C-B983-AFB1B8F24E8DQ34310781-72C9C05A-CFD1-4EDE-9968-CD30CE0050B8Q34509157-5A8B2D45-36E0-4084-9A5A-3B87D96E7B98Q38939454-95CDF1AE-E5A5-43FB-8E3A-C5FD7323F728Q39178846-88C888C0-68F6-4329-81DC-3274E25F6780Q39658746-BF833971-9193-41AA-893F-3F34871A1775Q47303335-D65016B3-F7DE-4D4B-B2D3-23D383CAD0A1Q57184388-CFCFEFA7-313E-4234-81DA-426A58CD340CQ60212500-8CDB7AAA-0FF2-4878-8400-49E51B394F99
P50
description
investigador
@es
researcher
@en
name
Olivier Zava
@en
type
label
Olivier Zava
@en
prefLabel
Olivier Zava
@en
P31
P496
0000-0001-6196-4709